Your browser doesn't support javascript.
loading
Effectiveness and safety of lanadelumab in ethnic and racial minority subgroups of patients with hereditary angioedema: results from phase 3 studies.
Craig, Timothy J; Zaragoza-Urdaz, Rafael H; Li, H Henry; Yu, Ming; Ren, Hong; Juethner, Salomé; Anderson, John.
Affiliation
  • Craig TJ; Allergy Asthma and Immunology, Departments of Medicine, Pediatrics, Biomedical Sciences, Penn State University, 500 University Drive, Hershey, PA, 17033, USA. tcraig@pennstatehealth.psu.edu.
  • Zaragoza-Urdaz RH; University of Puerto Rico School of Medicine, UPH, San Juan, Puerto Rico, USA.
  • Li HH; Institute for Asthma and Allergy, Chevy Chase, MD, USA.
  • Yu M; Takeda Pharmaceuticals, Inc., Lexington, MA, USA.
  • Ren H; Cytel Inc., Cambridge, MA, USA.
  • Juethner S; Takeda Pharmaceuticals, Inc., Lexington, MA, USA.
  • Anderson J; Alabama Allergy & Asthma Center, an affiliate of AllerVie Health, Birmingham, AL, USA.
Allergy Asthma Clin Immunol ; 18(1): 85, 2022 Sep 24.
Article in En | MEDLINE | ID: mdl-36153561
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Allergy Asthma Clin Immunol Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Allergy Asthma Clin Immunol Year: 2022 Document type: Article Affiliation country: Country of publication: